Content area
The ISTH London 2022 Congress is the first held (mostly) face‐to‐face again since the COVID‐19 pandemic took the world by surprise in 2020. For 2 years we met virtually, but this year’s in‐person format will allow the ever‐so‐important and quintessential creativity and networking to flow again. What a pleasure and joy to be able to see everyone! Importantly, all conference proceedings are also streamed (and available recorded) online for those unable to travel on this occasion. This ensures no one misses out. The 2022 scientific program highlights new developments in hemophilia and its treatment, acquired and other inherited bleeding disorders, thromboinflammation, platelets and coagulation, clot structure and composition, fibrinolysis, vascular biology, venous thromboembolism, women’s health, arterial thrombosis, pediatrics, COVID‐related thrombosis, vaccine‐induced thrombocytopenia with thrombosis, and omics and diagnostics. These areas are elegantly reviewed in this Illustrated Review article. The Illustrated Review is a highlight of the ISTH Congress. The format lends itself very well to explaining the science, and the collection of beautiful graphical summaries of recent developments in the field are stunning and self‐explanatory. This clever and effective way to communicate research is revolutionary and different from traditional formats. We hope you enjoy this article and will be inspired by its content to generate new research ideas.
Details
Subject
Infections;
Stroke;
Thrombosis;
Hemophilia;
Cancer therapies;
Endothelium;
Extracellular matrix;
Pregnancy;
Biomarkers;
Viruses;
Severe acute respiratory syndrome;
Engineering;
Anticoagulants;
Blood platelets;
Bone marrow;
Inflammation;
Algorithms;
Disease prevention;
Preeclampsia;
Tumors;
Pathogenesis;
Coronaviruses;
Stem cells;
Multisystem inflammatory syndrome in children;
Proteins
Stroke;
Thrombosis;
Hemophilia;
Cancer therapies;
Endothelium;
Extracellular matrix;
Pregnancy;
Biomarkers;
Viruses;
Severe acute respiratory syndrome;
Engineering;
Anticoagulants;
Blood platelets;
Bone marrow;
Inflammation;
Algorithms;
Disease prevention;
Preeclampsia;
Tumors;
Pathogenesis;
Coronaviruses;
Stem cells;
Multisystem inflammatory syndrome in children;
Proteins
Identifier / keyword
Title
Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress
Author
Ariëns, Robert A 1 ; Hunt, Beverley J 2 ; Agbani, Ejaife O 3 ; Ahnström, Josefin 4 ; Ahrends, Robert 5 ; Alikhan, Raza 6 ; Assinger, Alice 7 ; Bagoly, Zsuzsa 8 ; Balduini, Alessandra 9 ; Barbon, Elena 10 ; Barrett, Christopher D 11 ; Batty, Paul 12 ; Jorge David Aivazoglou Carneiro 13 ; Wee Shian Chan 14 ; de Maat, Moniek 15 ; de Wit, Kerstin 16 ; Denis, Cécile 17 ; Ellis, Martin H 18 ; Eslick, Renee 19 ; Fu, Hongxia 20 ; Hayward, Catherine P M 21 ; Benoit Ho‐Tin‐Noé 22 ; Klok, Frederikus A 23 ; Kumar, Riten 24 ; Leiderman, Karin 25 ; Litvinov, Rustem I 26 ; Mackman, Nigel 27 ; McQuilten, Zoe 28 ; Neal, Matthew D 29 ; Parker, William A E 30 ; Preston, Roger J S 31 ; Rayes, Julie 32 ; Rezaie, Alireza R 33 ; Roberts, Lara N 34 ; Rocca, Bianca 35 ; Shapiro, Susan 36 ; Siegal, Deborah M 37 ; Sousa, Lirlândia P 38 ; Katsue Suzuki‐Inoue 39 ; Zafar, Tahira 40 ; Zhou, Jiaxi 41
1 University of Leeds, Leeds, UK
2 King’s Healthcare Partners, London, UK
3 Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
4 Centre for Haematology, Imperial College London, London, UK
5 Institute of Analytical Chemistry, University of Vienna, Vienna, Austria
6 Haemostasis & Thrombosis, University Hospital of Wales, Cardiff, UK
7 Medical University of Vienna, Vienna, Austria
8 Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Laboratory Sciences and ELKH‐DE Neurodegenerative and Cerebrovascular Research Group, University of Debrecen, Debrecen, Hungary
9 University of Pavia, Pavia, Italy
10 San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy
11 Division of Acute Care Surgery and Surgical Critical Care, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA; Koch Institute, Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; Division of Surgical Critical Care, Department of Surgery, Boston University Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA
12 Royal Free Hospital, London, UK
13 Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
14 University of British Columbia, Vancouver, British Columbia, Canada
15 Department of Hematology, Erasmus MC, Rotterdam, The Netherlands
16 Queen’s University and McMaster University, Kingston, ON, Canada
17 INSERM UMRS 1176, Le Kremlin‐Bicetre Cedex, France
18 Hematology Institute and Blood Bank, Meir Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
19 Haematology Department, Canberra Hospital, Garran, Australian Capital Territory, Australia
20 Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA
21 Hamilton Health Sciences, McMaster University Medical Center, Hamilton, Ontario, Canada
22 INSERM Unit 1148, Paris, France
23 Department of Medicine – Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
24 Dana Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts, USA
25 Colorado School of Mines, Golden, Colorado, USA
26 Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
27 UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
28 Monash University, Melbourne, Victoria, Australia
29 Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
30 Cardiovascular Research Unit, Northern General Hospital, University of Sheffield, Sheffield, UK
31 Irish Centre for Vascular Biology, Department of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland
32 University of Birmingham, Birmingham, UK
33 Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA
34 King’s Thrombosis Centre, Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, UK
35 Department of Safety and Bioethics, Section of Pharmacology, Catholic University School of Medicine, Rome, Italy
36 Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, Oxford University, Oxford, UK
37 Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada
38 Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
39 Department of Clinical and Laboratory Medicine, University of Yamanashi, Yamanashi, Japan
40 Frontier Medical College, Abbotabad, Pakistan; Hemophilia Treatment Center, Rawalpindi, Pakistan
41 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
1 University of Leeds, Leeds, UK
2 King’s Healthcare Partners, London, UK
3 Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
4 Centre for Haematology, Imperial College London, London, UK
5 Institute of Analytical Chemistry, University of Vienna, Vienna, Austria
6 Haemostasis & Thrombosis, University Hospital of Wales, Cardiff, UK
7 Medical University of Vienna, Vienna, Austria
8 Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Laboratory Sciences and ELKH‐DE Neurodegenerative and Cerebrovascular Research Group, University of Debrecen, Debrecen, Hungary
9 University of Pavia, Pavia, Italy
10 San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy
11 Division of Acute Care Surgery and Surgical Critical Care, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA; Koch Institute, Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; Division of Surgical Critical Care, Department of Surgery, Boston University Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA
12 Royal Free Hospital, London, UK
13 Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
14 University of British Columbia, Vancouver, British Columbia, Canada
15 Department of Hematology, Erasmus MC, Rotterdam, The Netherlands
16 Queen’s University and McMaster University, Kingston, ON, Canada
17 INSERM UMRS 1176, Le Kremlin‐Bicetre Cedex, France
18 Hematology Institute and Blood Bank, Meir Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
19 Haematology Department, Canberra Hospital, Garran, Australian Capital Territory, Australia
20 Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA
21 Hamilton Health Sciences, McMaster University Medical Center, Hamilton, Ontario, Canada
22 INSERM Unit 1148, Paris, France
23 Department of Medicine – Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
24 Dana Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts, USA
25 Colorado School of Mines, Golden, Colorado, USA
26 Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
27 UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
28 Monash University, Melbourne, Victoria, Australia
29 Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
30 Cardiovascular Research Unit, Northern General Hospital, University of Sheffield, Sheffield, UK
31 Irish Centre for Vascular Biology, Department of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland
32 University of Birmingham, Birmingham, UK
33 Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA
34 King’s Thrombosis Centre, Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, UK
35 Department of Safety and Bioethics, Section of Pharmacology, Catholic University School of Medicine, Rome, Italy
36 Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Radcliffe Department of Medicine, Oxford University, Oxford, UK
37 Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada
38 Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
39 Department of Clinical and Laboratory Medicine, University of Yamanashi, Yamanashi, Japan
40 Frontier Medical College, Abbotabad, Pakistan; Hemophilia Treatment Center, Rawalpindi, Pakistan
41 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Volume
6
Issue
5
Publication year
2022
Publication date
Jul 2022
Section
ILLUSTRATED REVIEWS
Place of publication
Kidlington
Country of publication
United Kingdom
Publication subject
e-ISSN
24750379
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
Online publication date
2022-07-06
Milestone dates
2022-07-06 (publishedOnlineFinalForm); 2022-05-27 (manuscriptReceived); 2022-05-27 (manuscriptAccepted)
Publication history
First posting date
06 Jul 2022
ProQuest document ID
2701338076
Document URL
https://www.proquest.com/scholarly-journals/illustrated-state-art-capsules-isth-2022-congress/docview/2701338076/se-2?accountid=208611
Copyright
© 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2023-12-03
Database